Potential impact of AUSFTA on Australia's blood supply

Hilary J Bambrick and Thomas A Faunce
Med J Aust 2007; 186 (8): . || doi: 10.5694/j.1326-5377.2007.tb00985.x
Published online: 16 April 2007

In reply: Turner and Farrugia highlight important issues about the safety and supply of Australia’s blood and plasma that constituted key findings of the recent Australian Government review of Australia’s plasma fractionation arrangements.1 These included the desirability of self-sufficiency and the need for a viable contingency plan in the event of local supply failing to meet demand, in the context of probable increased uncertainty in relevant security and supply circumstances.

  • Hilary J Bambrick
  • Thomas A Faunce

  • Australian National University, Canberra, ACT.


Competing interests:

Hilary Bambrick is related to Philip Flood, Chairman of the Plasma Fractionation Review Committee. He has had no input into this letter. Thomas Faunce is Project Director of an Australian Research Council (ARC) grant investigating the impact of international trade agreements on Australian medicines policy. The ARC was not consulted about the preparation of this letter.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.